Back
Verve Therapeutics Vs. Sage Therapeutics Industry Stock Comparison
Sell
1
VERV
Verve Therapeutics
Last Price:
6.04
Seasonality Move:
-35.34%
Sell
23
SAGE
Sage Therapeutics
Last Price:
5.82
Seasonality Move:
19.95%
Sell
1
Verve Therapeutics (VERV)
is a Sell
Is Verve Therapeutics a Buy, Sell or Hold?
- The current Verve Therapeutics [VERV] share price is $5.93. The Score for VERV is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- VERV is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
23
Sage Therapeutics (SAGE)
is a Sell
Is Sage Therapeutics a Buy, Sell or Hold?
- The current Sage Therapeutics [SAGE] share price is $6.05. The Score for SAGE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- SAGE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VERV Stock Price Chart
What is Verve Therapeutics's stock price today?
-
The Verve Therapeutics share price today is $5.93
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VERV is experiencing buying pressure, which is a positive indicator for future bullish movement.
SAGE Stock Price Chart
What is Sage Therapeutics's stock price today?
-
The Sage Therapeutics share price today is $6.05
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SAGE is experiencing slight buying pressure.
VERV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.2 | Buy |
Relative Strength Index (14 RSI): | 60.64 | Buy |
Chaikin Money Flow: | 968401 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.77 - 5.79) | Buy |
Bollinger Bands (100): | (4.8 - 6.44) | Buy |
SAGE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.13 | Sell |
Relative Strength Index (14 RSI): | 34.79 | Sell |
Chaikin Money Flow: | 342651 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.43 - 7.79) | Sell |
Bollinger Bands (100): | (7.06 - 10.8) | Sell |
VERV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.83 | Buy |
20-day SMA: | 5.39 | Buy |
50-day SMA: | 5.39 | Buy |
200-day SMA: | 7.76 | Sell |
8-day EMA: | 5.79 | Buy |
20-day EMA: | 5.56 | Buy |
50-day EMA: | 5.49 | Buy |
200-day EMA: | 7.7 | Sell |
SAGE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.39 | Sell |
20-day SMA: | 7.12 | Sell |
50-day SMA: | 7.41 | Sell |
200-day SMA: | 13.47 | Sell |
8-day EMA: | 7.01 | Sell |
20-day EMA: | 7.21 | Sell |
50-day EMA: | 7.69 | Sell |
200-day EMA: | 13.06 | Sell |
Verve Therapeutics Earnings Growth & VERV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.68 per share, and a decrease next year of $0.28 per share.
Sage Therapeutics Earnings Growth & SAGE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.43 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.15 per share, and an increase next year of $2.10 per share.
Verve Therapeutics Technical Analysis
Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sage Therapeutics Technical Analysis
Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |